Ceribell Boosts Market Position: CEO Shares Sold While Launching FDA‑Cleared AI Delirium‑Monitoring Solution
Ceribell launches FDA‑cleared AI delirium‑monitor, unlocking Medicare revenue while top exec sells shares, boosting its health‑tech market edge.
2 minutes to read
